Aehr Test Systems Q3 2024 Adj EPS $(0.03) Beats $(0.04) Estimate, Sales $7.600M Miss $7.609M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aehr Test Systems (AEHR) reported Q3 2024 adjusted EPS of $(0.03), beating the $(0.04) estimate, but missed sales estimates with $7.600M versus the expected $7.609M. This represents a 55.83% decrease in sales compared to the same period last year.
April 09, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Aehr Test Systems reported a mixed Q3 2024 with an EPS beat but a slight miss on sales estimates and a significant year-over-year sales decrease.
The EPS beat might provide some positive sentiment, but the slight miss on sales and significant decrease in sales year-over-year could raise concerns about growth and operational efficiency. The mixed nature of the report makes the short-term impact on the stock price uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100